-
1
-
-
0001358613
-
Clinical use of serum digoxin concentrations
-
1. Lewis RP. Clinical use of serum digoxin concentrations. Am J Cardiol 1992; 39: 767-75.
-
(1992)
Am J Cardiol
, vol.39
, pp. 767-775
-
-
Lewis, R.P.1
-
3
-
-
0022209452
-
Lack of specificity of current anti-digoxin antibodies, and preparation of a new, specific, polyclonal antibody that recognizes the carbohydrate moiety of digoxin
-
3. Thong B, Soldin SJ, Lingwood CA. Lack of specificity of current anti-digoxin antibodies, and preparation of a new, specific, polyclonal antibody that recognizes the carbohydrate moiety of digoxin. Clin Chem 1985; 31: 1625-31.
-
(1985)
Clin Chem
, vol.31
, pp. 1625-1631
-
-
Thong, B.1
Soldin, S.J.2
Lingwood, C.A.3
-
4
-
-
0022916150
-
Digoxin - Issues and controversies (review)
-
4. Soldin SJ. Digoxin - issues and controversies (review). Clin Chem 1986; 32: 5-12.
-
(1986)
Clin Chem
, vol.32
, pp. 5-12
-
-
Soldin, S.J.1
-
5
-
-
0023073837
-
Endogenous digitalis-like natriuretic factors
-
5. Graves SW, Williams GH. Endogenous digitalis-like natriuretic factors. Ann Rev Med 1987; 38: 433-44.
-
(1987)
Ann Rev Med
, vol.38
, pp. 433-444
-
-
Graves, S.W.1
Williams, G.H.2
-
6
-
-
0022248671
-
Endogenous digoxin-like immunoreactive factors: Impact on digoxin measurements and potential physiological implications
-
6. Valdes R Jr. Endogenous digoxin-like immunoreactive factors: impact on digoxin measurements and potential physiological implications [Review]. Clin Chem 1985; 31: 1525-32.
-
(1985)
Clin Chem
, vol.31
, pp. 1525-1532
-
-
Valdes R., Jr.1
-
7
-
-
0025895057
-
Isolation of digoxin-like immunoreactive factors from mammalian adrenal cortex
-
7. Shaikh IM, Lau BW, Siegfried BA, Valdes R. Isolation of digoxin-like immunoreactive factors from mammalian adrenal cortex. J Biol Chem 1991; 266: 13672-8.
-
(1991)
J Biol Chem
, vol.266
, pp. 13672-13678
-
-
Shaikh, I.M.1
Lau, B.W.2
Siegfried, B.A.3
Valdes, R.4
-
8
-
-
0026773836
-
Endogenous digitalis-like factors
-
8. Schoner W. Endogenous digitalis-like factors. Clin Exp Hypertens A1992; 14: 767-814.
-
(1992)
Clin Exp Hypertens A
, vol.14
, pp. 767-814
-
-
Schoner, W.1
-
9
-
-
0024206305
-
Endogenous cardiac glycoside-like substances in newborns, adults, pregnant women and patients with hypertension or renal insufficiency
-
9. Clerico A, Balzan S, Del CMG, Paci A, Cocci F, Bertelli A. Endogenous cardiac glycoside-like substances in newborns, adults, pregnant women and patients with hypertension or renal insufficiency. Drugs Exp Clin Res 1988; 14: 603-7.
-
(1988)
Drugs Exp Clin Res
, vol.14
, pp. 603-607
-
-
Clerico, A.1
Balzan, S.2
Del, C.M.G.3
Paci, A.4
Cocci, F.5
Bertelli, A.6
-
10
-
-
0025240652
-
A longitudinal study of maternal digoxin-like immunoreactive substances in normotensive pregnancy and pregnancy-induced hypertension
-
10. Kerkez SA, Poston L, Wolfe CD, Quartero HW, Carabelli P, Petruckevitch A, et al. A longitudinal study of maternal digoxin-like immunoreactive substances in normotensive pregnancy and pregnancy-induced hypertension. Am J Obstet Gynecol 1990; 162: 783-7.
-
(1990)
Am J Obstet Gynecol
, vol.162
, pp. 783-787
-
-
Kerkez, S.A.1
Poston, L.2
Wolfe, C.D.3
Quartero, H.W.4
Carabelli, P.5
Petruckevitch, A.6
-
11
-
-
0021886445
-
Measuring endogenous digoxin-like substance and exogenous digoxin in the serum of low-birth-weight infants
-
11. Ng PK, LeGatt D, Coates J, Collins-Nakai RL. Measuring endogenous digoxin-like substance and exogenous digoxin in the serum of low-birth-weight infants. Am J Hosp Pharm 1985; 42: 1977-9.
-
(1985)
Am J Hosp Pharm
, vol.42
, pp. 1977-1979
-
-
Ng, P.K.1
LeGatt, D.2
Coates, J.3
Collins-Nakai, R.L.4
-
12
-
-
0024314920
-
Antibody specificity reduces interference by endogenous digoxin-like immunoreactive factors
-
12. Matheke ML, Valdes R Jr. Antibody specificity reduces interference by endogenous digoxin-like immunoreactive factors. J Clin Immunoassay 1989; 12: 115-21.
-
(1989)
J Clin Immunoassay
, vol.12
, pp. 115-121
-
-
Matheke, M.L.1
Valdes R., Jr.2
-
13
-
-
0022898235
-
Methods for eliminating interferences in digoxin immunoassays caused by digoxin-like factors
-
13. Graves SW, Sharma K, Chandler AB. Methods for eliminating interferences in digoxin immunoassays caused by digoxin-like factors. Clin Chem 1986; 32: 1506-9.
-
(1986)
Clin Chem
, vol.32
, pp. 1506-1509
-
-
Graves, S.W.1
Sharma, K.2
Chandler, A.B.3
-
14
-
-
0025978324
-
Digoxin-like immunoreactivity in serum from neonates and infants reduced by centrifugal ultrafiltration and fluorescence polarization immunoassay
-
14. Ray JE, Crisan D, Howrie DL. Digoxin-like immunoreactivity in serum from neonates and infants reduced by centrifugal ultrafiltration and fluorescence polarization immunoassay. Clin Chem 1991; 37: 94-8.
-
(1991)
Clin Chem
, vol.37
, pp. 94-98
-
-
Ray, J.E.1
Crisan, D.2
Howrie, D.L.3
-
15
-
-
0025787416
-
pH-dependent column fractionation for characterization of endogenous digoxin-like immunoreactive factors in pregnant urine
-
15. Homma M, Hirano T, Oka K. pH-dependent column fractionation for characterization of endogenous digoxin-like immunoreactive factors in pregnant urine. Biomed Chromatog 1991; 5: 175-9.
-
(1991)
Biomed Chromatog
, vol.5
, pp. 175-179
-
-
Homma, M.1
Hirano, T.2
Oka, K.3
-
16
-
-
0030023124
-
Analytical performance of a monoclonal digoxin assay with increased specificity on the ACS:180
-
16. Miller JJ, Straub RW Jr, and Valdes R Jr. Analytical performance of a monoclonal digoxin assay with increased specificity on the ACS:180. Ther Drug Monit 1996; 18: 65-72.
-
(1996)
Ther Drug Monit
, vol.18
, pp. 65-72
-
-
Miller, J.J.1
Straub R.W., Jr.2
Valdes R., Jr.3
-
17
-
-
0029937715
-
Effect of antibody specificity on results of selected digoxin immunoassays among various clinical groups
-
17. Datta P, Xu L, Malik S, et al. Effect of antibody specificity on results of selected digoxin immunoassays among various clinical groups. Clin Chem 1996; 42: 373-379.
-
(1996)
Clin Chem
, vol.42
, pp. 373-379
-
-
Datta, P.1
Xu, L.2
Malik, S.3
-
18
-
-
0028061664
-
Digoxin immunoassay with cross-reactivity of digoxin metabolites proportional to their biological activity
-
18. Miller JJ, Straub RW, Valdes R. Digoxin immunoassay with cross-reactivity of digoxin metabolites proportional to their biological activity. Clin Chem 1994; 40: 1898-1903.
-
(1994)
Clin Chem
, vol.40
, pp. 1898-1903
-
-
Miller, J.J.1
Straub, R.W.2
Valdes, R.3
-
19
-
-
0028359235
-
Specificity of digoxin immunoassays toward digoxin metabolites
-
19. Datta P, Larsen F. Specificity of digoxin immunoassays toward digoxin metabolites [Letter]. Clin Chem 1994; 40: 1348-9.
-
(1994)
Clin Chem
, vol.40
, pp. 1348-1349
-
-
Datta, P.1
Larsen, F.2
-
20
-
-
0021881532
-
Protein binding of endogenous digoxin like immunoreactive factor in human serum and its variation with clinical condition
-
20. Valdes R, Graves SW. Protein binding of endogenous digoxin like immunoreactive factor in human serum and its variation with clinical condition. J Clin Endocrinol Metab 1985; 60: 1135-43.
-
(1985)
J Clin Endocrinol Metab
, vol.60
, pp. 1135-1143
-
-
Valdes, R.1
Graves, S.W.2
-
21
-
-
0026320460
-
Binding of endogenous digoxin-like immunoreactive factor to serum proteins during normal and hypertensive pregnancy
-
21. Craig HR, Knight A, Valdes R Jr. Binding of endogenous digoxin-like immunoreactive factor to serum proteins during normal and hypertensive pregnancy. J Clin Immunoassay 1991; 14: 245-50.
-
(1991)
J Clin Immunoassay
, vol.14
, pp. 245-250
-
-
Craig, H.R.1
Knight, A.2
Valdes R., Jr.3
|